Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Oral laquinimod for multiple sclerosis.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Early detection of MS treatment complication may improve survival
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Physician-patient communication skills: e-tools.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Aging, widowhood, multiple sclerosis, and a dog.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
A nurse-led mental health service for people with multiple sclerosis.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
[Anti-NMDA receptor encephalitis - case report].
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Antidepressant activity of fingolimod in mice.
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
[New treatment options in multiple sclerosis and their complications].
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.

Pages